D-Wave Quantum: A Tangle of Conflicting Signals as Bookings Soar and Price Targets Fall
Published on 08/14/2026 at 03:21 | Redaktion boerse-global.de
There is a curious disconnect playing out around D-Wave Quantum right now. The stock has clawed back some ground in recent weeks, yet the analyst community has spent the past several days trimming price targets. At the same time, the company's order book is growing at a pace that would make most enterprise software firms envious — while its income statement tells a far more subdued story.
Shares last changed hands at €18.45, up 2.7 percent on the day, after closing the previous session at €18.16. That leaves the equity roughly 1.4 percent above its level of seven trading days ago and 14 percent higher on a monthly basis. But the year-to-date picture remains firmly in the red, with the stock down about 20 percent. The gap to the 52-week high of $40.41, set last October, stands at 55 percent, while the distance from the late-March low is 63 percent.
A Bookings Boom That Outruns the Revenue Line
The headline number from the company's August 6 fiscal second-quarter report was the bookings figure: $35.5 million for the first half of 2026, a year-over-year surge of more than 1,120 percent. Remaining performance obligations climbed 668 percent to $40.7 million over the same stretch. A $20 million systems contract with Florida Atlantic University did much of the heavy lifting.
The second quarter alone saw bookings rise 59 percent to $2.1 million, with the average deal size expanding 87 percent. Revenue, however, was flat at $3.1 million, and the GAAP loss per share of $0.13 came in roughly 30 percent wider than the $0.10 analysts had penciled in. Management reiterated its guidance for two system deliveries in 2026 and cautioned that the bulk of full-year revenue is expected to land in the fourth quarter — a backloaded profile that does little to soothe near-term concerns.
The customer mix is shifting too. Commercial clients contributed 62.4 percent of second-quarter revenue, up from 45.1 percent a year earlier, as research institutions fade into the background as a revenue source. Profitability took a hit from rising personnel costs, which compressed gross margin by 8.4 percentage points.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The Cash Question
The balance sheet shows the cost of ambition. As of June 30, D-Wave held $546.2 million in cash and marketable securities, down $273.1 million — or 33 percent — from the prior-year date. More than 90 percent of that decline traces to the cash component of the Quantum Circuits acquisition, paid in January.
That cash burn is part of the reason analysts are tempering their enthusiasm even as they hold their ratings. Mizuho's Vijay Rakesh cut his target from $35 to $29 on Thursday while keeping an "Outperform" call. Jefferies, Evercore ISI and Northland Securities followed a similar pattern, trimming targets to $40, $37 and $22 respectively without abandoning their underlying ratings. Craig-Hallum Capital Group and Cantor Fitzgerald reaffirmed their buy recommendations outright, while Northland initiated coverage with a neutral stance. Wedbush's Matt Bryson, who started coverage on August 3 with an "Outperform" and a $40 target, cited both commercial traction and the technology roadmap as reasons for optimism.
Science Advances, Funding Ticks Over
Amid the financial noise, the research engine keeps humming. On August 5, D-Wave published a study in Nature detailing a fast, high-precision two-qubit gate that preserves the error-correction properties of its superconducting dual-rail qubit architecture. The company claims roughly 99.9 percent accuracy with switching times of 500 nanoseconds — a building block for its fault-tolerant gate-model roadmap, which targets a 17-qubit system by the end of 2026 and 100 logical qubits by 2032.
A smaller but symbolically telling development came midweek: the National Research Council of Canada awarded D-Wave up to C$300,000 under its Applied Quantum Computing Challenge program, funding work on annealing software and graph-minor-embedding algorithms for the Advantage2 system. The sum is trivial next to the company's losses, but it underscores how reliant the quantum sector remains on public research money rather than organic revenue growth. The company also announced a collaboration with Nasdaq Verafin on fraud detection in the financial sector earlier this month.
A Listing Move and Insider Sales
Two other items round out the picture. D-Wave shifted its listing from the New York Stock Exchange to the Nasdaq on July 27, trading under its existing ticker. And late last month, several executives — including CEO Alan Baratz and CFO John Markovich — sold a combined 68,173 shares at $18.66 apiece, filings show, with the proceeds going exclusively to cover tax obligations tied to vesting restricted stock units.
The tension at the heart of D-Wave's story is straightforward: the science is advancing, the pipeline is filling, and the commercial customer base is growing — but the revenue line has yet to catch up, and the market is left to weigh a bookings surge against a still-distant payoff. For now, analysts seem to believe in the destination while doubting the speed of the journey.
Ad
D-Wave Quantum Stock: New Analysis - 14 August
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
